Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Hauben

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Pharmacoepidemiology and Drug Safety|November 19, 2013
Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databasesFrancois Maignen, Manfred Hauben, Eric Hung, et al.
Pharmacoepidemiology and Drug Safety|November 19, 2013
A conceptual approach to the masking effect of measures of disproportionalityFrancois Maignen, Manfred Hauben, Eric Hung, et al.
Drug Safety|August 6, 2015
Safety of Perflutren Ultrasound Contrast Agents: A Disproportionality Analysis of the US FAERS DatabaseManfred Hauben, Eric Y Hung, Kelly C Hanretta, et al.
European Journal of Clinical Pharmacology|January 7, 2021
Maternal paracetamol intake and fetal ductus arteriosus constriction/closure: comprehensive signal evaluation using the Austin Bradford Hill criteriaManfred Hauben, Stephen Bai, Eric Hung, et al.
European Journal of Clinical Pharmacology|August 26, 2021
Response/comments to maternal paracetamol intake and fetal ductus arteriosus closure: adding pieces to the scenery-Karel Allegaert, Michael Ceulemans, John van den AnkeManfred Hauben, Stephen Bai, Eric Hung, et al.
Expert Opinion on Drug Safety|August 23, 2005
The role of data mining in pharmacovigilanceManfred Hauben, David Madigan, Charles M Gerrits, et al.
Journal of Clinical Pharmacology|May 20, 2009
Systematic investigation of time windows for adverse event data mining for recently approved drugsAlan M Hochberg, Manfred Hauben, Ronald K Pearson, et al.
European Journal of Clinical Pharmacology|August 10, 2006
Data mining in pharmacovigilance: lessons from phantom shipsManfred Hauben, Lester Reich, Eugène P Van Puijenbroek, et al.
Therapeutic Advances in Drug Safety|December 12, 2025
How LLMs can advance safety case intake-points to consider and insights from a proof of conceptHans-Joerg Roemming, Manfred Hauben, Wei Wannhoff, et al.
Drug Safety|December 24, 2022
Individual Case Safety Report Replication: An Analysis of Case Reporting Transmission NetworksJohn van Stekelenborg, Vijay Kara, Roman Haack, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Pharmacoepidemiology and Drug Safety|November 19, 2013
Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databasesFrancois Maignen, Manfred Hauben, Eric Hung, et al.
Pharmacoepidemiology and Drug Safety|November 19, 2013
A conceptual approach to the masking effect of measures of disproportionalityFrancois Maignen, Manfred Hauben, Eric Hung, et al.
Drug Safety|August 6, 2015
Safety of Perflutren Ultrasound Contrast Agents: A Disproportionality Analysis of the US FAERS DatabaseManfred Hauben, Eric Y Hung, Kelly C Hanretta, et al.
European Journal of Clinical Pharmacology|January 7, 2021
Maternal paracetamol intake and fetal ductus arteriosus constriction/closure: comprehensive signal evaluation using the Austin Bradford Hill criteriaManfred Hauben, Stephen Bai, Eric Hung, et al.
European Journal of Clinical Pharmacology|August 26, 2021
Response/comments to maternal paracetamol intake and fetal ductus arteriosus closure: adding pieces to the scenery-Karel Allegaert, Michael Ceulemans, John van den AnkeManfred Hauben, Stephen Bai, Eric Hung, et al.
Expert Opinion on Drug Safety|August 23, 2005
The role of data mining in pharmacovigilanceManfred Hauben, David Madigan, Charles M Gerrits, et al.
Journal of Clinical Pharmacology|May 20, 2009
Systematic investigation of time windows for adverse event data mining for recently approved drugsAlan M Hochberg, Manfred Hauben, Ronald K Pearson, et al.
European Journal of Clinical Pharmacology|August 10, 2006
Data mining in pharmacovigilance: lessons from phantom shipsManfred Hauben, Lester Reich, Eugène P Van Puijenbroek, et al.
Therapeutic Advances in Drug Safety|December 12, 2025
How LLMs can advance safety case intake-points to consider and insights from a proof of conceptHans-Joerg Roemming, Manfred Hauben, Wei Wannhoff, et al.
Drug Safety|December 24, 2022
Individual Case Safety Report Replication: An Analysis of Case Reporting Transmission NetworksJohn van Stekelenborg, Vijay Kara, Roman Haack, et al.
Pageof 12